A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies

Cardiac amyloidosis (CA), a significant condition resulting in infiltrative cardiomyopathy and heart failure with preserved ejection fraction (HFpEF), is caused by extracellular deposition of amyloid fibrils in the heart. Even though this has been known for an extended period, its prevalence in elde...

Descripción completa

Detalles Bibliográficos
Autores principales: Raval, Maharshi, Siddiq, Sajid, Sharma, Kamal, Sanghvi, Labdhi, Jain, Akhil, Patel, Sagar, Trivedi, Jaahnavee, Uttam Chandani, Kanishka, Patel, Dhriti, Desai, Rupak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995736/
https://www.ncbi.nlm.nih.gov/pubmed/36911240
http://dx.doi.org/10.12688/f1000research.130285.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995736/
https://www.ncbi.nlm.nih.gov/pubmed/36911240
http://dx.doi.org/10.12688/f1000research.130285.1

Ejemplares similares